The Anna-Monika-Foundation is proud to announce the prize winners of the 28th Anna-Monika Prize for Depression Research

In the News

Learn More

Breadcrumb

  1. In the News
  2. The Anna-Monika-Foundation is proud to announce the pri...

The Anna-Monika-Foundation is proud to announce the prize winners of the 28th Anna-Monika Prize for Depression Research

Press Release Anna-Monika-Foundation 2023 (alphabetical--so I'm last)

The Anna-Monika-Foundation is proud to announce the prize winners of the 28th Anna-Monika call. In view of a number of excellent applications it was a quite difficult task for the jury to come up with a selection. In any case, the decision follows the outstanding nominations in the history of the Anna-Monika-Foundation.

prize has been awarded to Helen S. Mayberg, Mount Sinai School of Medicine, New York, USA for her work on brain circuits relevant for developing novel treatments for depression. In particular, she has discovered Brodmann area 25 (BA25) as a key region for the pathophysiology of depression and as a target for deep brain stimulation. Moreover, she has identified neuroimaging-based biomarkers for predicting antidepressant treatment response.

Another prize has been awarded to Lisa Monteggia and Ege Kavalali, Vanderbilt University, Nashville, Tennessee, USA for their work on rapid mechanisms of action of ketamine as an antidepressant. They have identified a brain derived neurotrophic factor (BDNF) as a mediator of ketamine´s action in depression. Moreover, they have discovered an intracellular signal transduction pathway activated by ketamine-induced blockade of synaptic NMDA receptors relevant for synaptic potentiation.

prize has also been awarded to Mark Rasenick, University of Illinois, Chicago, USA for his work on the importance of lipid rafts for signal transduction mediated by antidepressants and ketamine. He has identified the localization of Gsαwithin the cell membrane as crucial for antidepressant treatment both in preclinical and clinical studies and has developed a respective biomarker predicting treatment response.

Featured Profile

Mark Rasenick PhD

  • Distinguished Professor of Physiology & Biophysics and Psychiatry
  • Director, Biomedical Neuroscience Training Program
  • Research Career Scientist, Jesse Brown VAMC
  • University of Illinois Chicago College of Medicine

312-996-6641
razatuic [dot] edu